Veppanu represents a scientific milestone as the first-ever proteolysis-targeting chimera (PROTAC) to receive FDA approval.
More than a decade ago, Yale chemist Craig Crews founded a biotechnology company in New Haven based on his pioneering ...
Earnings beat: Pfizer's Q1 adjusted EPS of $0.75 beat estimates, with revenue up 5% to $14.5B, driven by 22% growth in launched and acquired products. Covid drag continues: Comirnaty and Paxlovid ...
New degradation shortcut: Scientists designed molecules that send harmful cancer proteins straight to the proteasome, skipping the standard ubiquitination step. Restoring drug sensitivity: Targeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results